Fluidigm secures Caligan support for $250M Casdin/Viking capital infusion; appoints Frank Witney to board

STANDARD BIOTOOLS INC.

Caligan, largest common holder, agrees to vote FOR all proposals at special meeting reconvening April 1, 2022.
$250M strategic capital infusion from Casdin Capital and Viking Global to fund growth.
Board will appoint Frank Witney (former Affymetrix CEO) as director, conditional on transaction close.
Board expands to eight directors upon appointment of Witney.
Company urges all stockholders to vote FOR; transaction terminated if not approved.

item 1.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Franklin R. Witney

Director

LAB · STANDARD BIOTOOLS INC.

Filed: March 29, 2022, 7:59 PM ET

the Board appointed Franklin R. Witney to serve as a member of the Board

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Franklin R. Witney was appointed as Director at STANDARD BIOTOOLS INC..

Action: appointed
Role: Director

Exact text from the filing

the Board appointed Franklin R. Witney to serve as a member of the Board

View on SEC.gov

STANDARD BIOTOOLS INC. filing history →

Source: SEC EDGAR

accession 0001193125-22-087550

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.